A personalised algorithm predicting the risk of intravenous corticosteroid failure in acute ulcerative colitis

被引:3
作者
Croft, Anthony [1 ,2 ,3 ]
Okano, Satomi [2 ]
Hartel, Gunter [2 ]
Lord, Anton [2 ]
Walker, Gareth [1 ,2 ,3 ]
Tambakis, George [1 ,2 ,3 ]
Radford-Smith, Graham [1 ,2 ,3 ]
机构
[1] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
[2] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia
[3] Univ Queensland, Fac Med, Brisbane, Qld, Australia
关键词
INFLAMMATORY-BOWEL-DISEASE; ENDOSCOPIC INDEX; SALVAGE THERAPY; CYCLOSPORINE; COLECTOMY; OUTCOMES; TOFACITINIB; NEED;
D O I
10.1111/apt.18190
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundAn episode of acute ulcerative colitis (UC) represents an important watershed moment in a patient's disease course.AimsTo derive a personalised algorithm for identifying patients at high risk of corticosteroid non-response from variables available at hospital presentation using a large prospectively collected acute UC patient database and machine learning-based techniques.MethodsWe analysed data from 682 consecutive presentations of acute UC. We used an Akaike information criterion-based elastic net model to select variables based on the 419 earliest presentations of acute UC (1996-2017). We constructed two risk-scoring algorithms, with and without utilising additional endoscopic variables, using logistic regression models. We validated these risk scores on separate cohorts of 181 (2018-2022) and 82 (2015-2022) acute UC presentations.ResultsThe partial risk of rescue (ROR) score included the admission indices of oral corticosteroid treatment, bowel frequency >= 6/24 h, albumin, CRP >= 12 mg/mL and log10CRP. The full ROR score incorporates the same variables with the addition of the Mayo endoscopic subscore and disease extent. The AUCs in the main validation cohort were 0.76 (95% CI: 0.69-0.83) and 0.78 (95% CI: 0.71-0.85) for the partial and full ROR scores, respectively.ConclusionsThese pragmatic personalised risk scores (available at ) have comparably strong performance characteristics and usability enabling the identification of individuals at high risk of corticosteroid non-response before or after endoscopic assessment. The ROR scores have the potential to challenge conventional acute UC treatment paradigms by identifying patients who may benefit from early rescue therapy or participation in relevant clinical trials. Partial and full risk of rescue (ROR) score derivation and validation. For online ROR score calculator visit image
引用
收藏
页码:921 / 933
页数:13
相关论文
共 32 条
[1]   Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response [J].
Adams, Alex ;
Gupta, Vipin ;
Mohsen, Waled ;
Chapman, Thomas P. ;
Subhaharan, Deloshaan ;
Ramaswamy, Pradeep Kakkadasam ;
Kumar, Sudheer ;
Kedia, Saurabh ;
McGregor, Colleen G. C. ;
Ambrose, Tim ;
George, Bruce D. ;
Palmer, Rebecca ;
Brain, Oliver ;
Walsh, Alissa ;
Ahuja, Vineet ;
Travis, Simon P. L. ;
Satsangi, Jack .
GUT, 2023, 72 (03) :433-442
[2]  
Al-Bawardy B, 2024, J CROHNS COLITIS, V18, pI1331
[3]   Corticosteroid exposure prior to admission and predicting need for rescue therapy in acute severe ulcerative colitis [J].
Barnes, Alex ;
Spizzo, Paul ;
Mountifield, Reme .
INTERNAL MEDICINE JOURNAL, 2022, 52 (05) :828-833
[4]   Predicting the Course of Disease in Hospitalized Patients With Acute Severe Ulcerative Colitis [J].
Bernardo, Sonia ;
Fernandes, Samuel Raimundo ;
Goncalves, Ana Rita ;
Valente, Ana ;
Baldaia, Cilenia ;
Santos, Paula Moura ;
Correia, Luis Araujo .
INFLAMMATORY BOWEL DISEASES, 2019, 25 (03) :541-546
[5]   Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis [J].
Burr, Nicholas E. ;
Gracie, David J. ;
Black, Christopher J. ;
Ford, Alexander C. .
GUT, 2022, 71 (10) :1976-+
[6]   Ciclosporin use in acute ulcerative colitis: a long-term experience [J].
Campbell, S ;
Travis, S ;
Jewell, D .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (01) :79-84
[7]   Tofacitinib Salvage Therapy for Children Hospitalized for Corticosteroid- and Biologic-Refractory Ulcerative Colitis [J].
Constant, Brad D. ;
Baldassano, Robert ;
Kirsch, Jacqueline ;
Mitchel, Elana B. ;
Stein, Ronen ;
Albenberg, Lindsey .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2022, 75 (06) :724-730
[8]   Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab [J].
Croft, A. ;
Walsh, A. ;
Doecke, J. ;
Cooley, R. ;
Howlett, M. ;
Radford-Smith, G. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (03) :294-302
[9]   Markers of Systemic Inflammation in Acute Attacks of Ulcerative Colitis: What Level of C-reactive Protein Constitutes Severe Colitis? [J].
Croft, Anthony ;
Lord, Anton ;
Radford-Smith, Graham .
JOURNAL OF CROHNS & COLITIS, 2022, 16 (07) :1089-1096
[10]   A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis [J].
D'Haens, Geert ;
Sandborn, William J. ;
Feagan, Brian G. ;
Geboes, Karel ;
Hanauer, Stephen B. ;
Irvine, E. Jan ;
Lemann, Marc ;
Marteau, Philippe ;
Rutgeerts, Paul ;
Scholmerich, Jurgen ;
Sutherland, Lloyd R. .
GASTROENTEROLOGY, 2007, 132 (02) :763-786